OR WAIT null SECS
August 15, 2023
Under the exclusive agreement, Hikma will commercialize products in Rakuten Medical’s pipeline for cancer treatment in the Middle East and North Africa region.
August 01, 2023
A proposed database includes key information about critical drugs, such as the country of origin and quantity, so supply chain weaknesses can be identified.
July 25, 2023
The damage to the facility, which produces 8% of US injectable drug consumption, should not significantly affect the current supply.
July 12, 2023
Cold chain stakeholders continue to innovate with new technology development, the use of advanced modeling and analytics capabilities, and the pursuit of strategic partnerships.
July 01, 2023
Problems continue despite actions by regulators to better prevent and address drug shortages.
June 01, 2023
Vaccine nationalism strengthens viruses and poses deadly risks for all involved.
May 18, 2023
Jane True, vice-president of mRNA Commercial Strategy & Innovation and Global Pandemic Security Lead, Pfizer, shares her perspective on how mRNA will shift commercial models in the pharmaceutical industry.
April 28, 2023
The event, cosponsored by FDA and USP, hosted regulators and industry leaders to discuss the challenges in strengthening the medical product supply chain.
April 04, 2023
A CPHI North America panel discussion forewarns that CDMO supply chains are potentially the biggest single risk to product resilience.
April 01, 2023
Makers of specialty biologics, gene therapies, and other personalized medicines are working to identify and reduce potential supply chain risks both upstream and downstream.